Delivery Order SPE2DB24D2205-SPE2DB24FDWGX

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $14,855.34, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. It has an ultimate completion date of July 8, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,564,792,418 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. The $20,129.39 firm-fixed-price contract has a completion date of June 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,905.57 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through May 9, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $56,896.00 firm-fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,865.61 firm fixed price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, to support federal healthcare programs. The award has an ultimate completion date of August 21, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
This is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,695.27 firm fixed-price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product used in healthcare. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The $8,452.60 firm fixed price contract has an ultimate completion date of August 14, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $4,647.12 to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,532.01, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. The contract has an ultimate completion date of June 4, 2024. Amerisourcebergen is the prime contractor for this delivery order contract, which is not designated as a set-aside. The company also holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,230.33 firm fixed-price delivery order is for the medical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of December 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWGX
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp., a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,402.41, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of July 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is not designated as a set-aside contract.

Generated 5/17/25, 9:51 AM